Moonlake Immunotherapeutics Share Price: MLTX (Moonlake Immunotherapeutics) Stock Price Today & Updates | INDmoney

Question 1

What is Moonlake Immunotherapeutics share price today?

Accepted Answer

Moonlake Immunotherapeutics (MLTX) share price today is {{live_price}}.

Question 2

Can Indians buy Moonlake Immunotherapeutics shares?

Accepted Answer

Yes, Indians can invest in the Moonlake Immunotherapeutics (MLTX) from India.

With INDmoney, you can buy Moonlake Immunotherapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Moonlake Immunotherapeutics at zero transaction cost.

Question 3

How can I buy Moonlake Immunotherapeutics shares from India?

Accepted Answer

It is very easy to buy Moonlake Immunotherapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Question 4

Can Fractional shares of Moonlake Immunotherapeutics be purchased?

Accepted Answer

Yes, you can buy fractional shares of Moonlake Immunotherapeutics with INDmoney app.

Question 5

What are the documents required to start investing in Moonlake Immunotherapeutics stocks?

Accepted Answer

To start investing in Moonlake Immunotherapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

Question 6

What are today’s High and Low prices of Moonlake Immunotherapeutics

Accepted Answer

Today’s highest price of Moonlake Immunotherapeutics (MLTX) is {{1_rba_end}}.

Today’s lowest price of Moonlake Immunotherapeutics (MLTX) is {{1_rba_st}}.

Question 7

What is today's market capitalisation of Moonlake Immunotherapeutics

Accepted Answer

Today's market capitalisation of Moonlake Immunotherapeutics MLTX is 3.0B

Question 8

What is the 52 Week High and Low Range of Moonlake Immunotherapeutics

Accepted Answer

52 Week High
{{rba_end}}
52 Week Low
{{rba_st}}

Question 9

How much percentage Moonlake Immunotherapeutics is down from its 52 Week High?

Accepted Answer

Moonlake Immunotherapeutics (MLTX) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

Question 10

How much percentage Moonlake Immunotherapeutics is up from its 52 Week low?

Accepted Answer

Moonlake Immunotherapeutics (MLTX) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

Question 11

What are the historical returns of Moonlake Immunotherapeutics?

Accepted Answer

1 Month Returns
{{1mr}}%
3 Months Returns
{{3mr}}%
1 Year Returns
{{1yr}}%
5 Years Returns
{{5yr}}%

Question 12

Who is the Chief Executive Officer (CEO) of Moonlake Immunotherapeutics

Accepted Answer

Dr. Jorge Santos da Silva is the current Chief Executive Officer (CEO) of Moonlake Immunotherapeutics.

Period	Moonlake Immunotherapeutics	Index (Russel 2000)
3 Months	9.49%	0.0%
6 Months	19.31%	0.0%
1 Year	-7.85%	0.0%
3 Years	299.51%	-23.0%

Market Capitalization	3.0B
Book Value	$8.28
Earnings Per Share (EPS)	-0.87
Wall Street Target Price	72.86

Profit Margin	0.0%
Operating Margin TTM	0.0%

Return On Assets TTM	-9.32%
Return On Equity TTM	-11.32%

Revenue TTM	0.0
Revenue Per Share TTM	0.0
Quarterly Revenue Growth YOY	0.0%
Gross Profit TTM	0.0
EBITDA	-78.3M
Diluted Eps TTM	-0.87
Quarterly Earnings Growth YOY	0.0

Moonlake Immunotherapeutics (MLTX)

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Technicals Summary

Peers

Vs ALNY

Institutional Holdings

Corporate Announcements

Moonlake Immunotherapeutics Earnings

Company Information

Discover More

FAQs

EPS Estimate Current Year	-1.54
EPS Estimate Next Year	-2.31
EPS Estimate Current Quarter	-0.28
EPS Estimate Next Quarter	-0.35

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Moonlake Immunotherapeutics	-11.66%	19.31%	-7.85%	299.51%	299.51%
Regeneron Pharmaceuticals, Inc.	-9.28%	10.06%	24.53%	74.0%	232.45%
Novo Nordisk A/s	-4.54%	-5.72%	21.59%	126.2%	349.01%
Alnylam Pharmaceuticals, Inc.	8.87%	102.98%	82.67%	44.83%	241.09%
Vertex Pharmaceuticals Incorporated	5.0%	20.77%	31.37%	158.16%	163.17%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Moonlake Immunotherapeutics	NA	NA	NA	-1.54	-0.11	-0.09	NA	8.28
Regeneron Pharmaceuticals, Inc.	26.41	26.41	1.37	44.9	0.17	0.08	NA	261.41
Novo Nordisk A/s	40.21	40.21	1.81	3.36	0.89	0.23	0.01	25.24
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-2.42	-15.01	0.02	NA	-0.02
Vertex Pharmaceuticals Incorporated	32.84	NA	0.59	0.18	-0.03	0.13	NA	57.26

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Moonlake Immunotherapeutics	Buy	$3.0B	299.51%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$110.0B	232.45%	26.41	32.04%
Novo Nordisk A/s	Buy	$529.8B	349.01%	40.21	34.84%
Alnylam Pharmaceuticals, Inc.	Buy	$38.1B	241.09%	NA	-3.11%
Vertex Pharmaceuticals Incorporated	Buy	$128.7B	163.17%	32.84	-4.74%

Organization	Moonlake Immunotherapeutics
Employees	50
CEO	Dr. Jorge Santos da Silva
Industry	Miscellaneous